Skip to content

Biogen BIIB EV / sales

EV / sales at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.4×
Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Royalty Pharma logo
Royalty PharmaRPRX
11.9×+3.0×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
3.3×-0.1×
Amgen logo
AmgenAMGN
6.6×+0.1×
Incyte logo
IncyteINCY
2.9×+0.6×

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Net income$319.5M+32.9%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.02B+34.3%
Enterprise value$32.2B+34.9%
P/E20.4×+5.8×
P/S2.9×+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Calculated from Biogen’s reported figures.

Based on the most recent quarter.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's EV / sales?
Biogen (BIIB) reported EV / sales of 3× in Q1 2026.
How has Biogen's EV / sales changed year-over-year?
Biogen's EV / sales increased by 33.2% year-over-year, from 2.3× to 3×.
What is the long-term trend for Biogen's EV / sales?
Over 4 years (2021 to 2025), Biogen's EV / sales has grown at a -12.3% compound annual growth rate (CAGR), from 16.5× to 9.8×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.